Search Results - "Ligneau, Blandine"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
  2. 2

    The influence of mutation site and age on the severity of duodenal polyposis in patients with familial adenomatous polyposis by Saurin, Jean-Christophe, Ligneau, Blandine, Ponchon, Thierry, Leprêtre, Jean, Chavaillon, Annick, Napoléon, Bertrand, Chayvialle, Jean-Alain

    Published in Gastrointestinal endoscopy (01-03-2002)
    “…Background: The present study was undertaken to identify factors affecting the severity of the duodenojejunal polyposis in patients with familial adenomatous…”
    Get full text
    Journal Article
  3. 3

    Role of gemcitabine in the treatment of other malignant tumors by Clippe, Christine, Ligneau, Blandine, Trillet-Lenoir, Véronique

    Published in Bulletin du cancer (01-08-2002)
    “…The therapeutic interest of gemcitabine both as a single drug and in combination is now well known and applied in various malignant diseases. However, it would…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Colony-stimulating factors in the prevention of solid tumors induced by chemotherapy in patients with febrile neutropenia by FREYER, G, LIGNEAU, B, TRILLET-LENOIR, V

    “…Haematologic toxicity and its most frequent complication, febrile neutropenia represents the main limiting factor to the use of anti-cancer chemotherapy. The…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Palliative hormone therapy, low-dose chemotherapy, and bisphosphonate in breast cancer patients with bone marrow involvement and pancytopenia: report of a pilot experience by Freyer, Gilles, Ligneau, Blandine, Trillet-Lenoir, Véronique

    Published in European journal of internal medicine (20-12-2000)
    “…Background: The choice between supportive care or specific anticancer treatment for poor performance status (PS) breast cancer patients with multimetastatic…”
    Get full text
    Journal Article
  8. 8

    A limited-sampling strategy for estimation of etoposide pharmacokinetics in cancer patients by TRANCHAND, B, AMSELLEM, C, CHATELUT, E, FREYER, G, ILIADIS, A, LIGNEAU, B, TRILLET-LENOIR, V, CANAL, P, LOCHON, I, ARDIET, C. J

    “…Etoposide (VP16), a widely used anticancer drug, is a topoisomerase II inhibitor. A number of studies have highlighted a correlation between hematologic…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Therapeutic advances in the management of metastatic colorectal cancer by Freyer, Gilles, Ligneau, Blandine, Kraft, Delphine, Descos, Louis, Trillet-Lenoir, Véronique

    Published in Expert review of anticancer therapy (01-08-2001)
    “…Metastatic colorectal cancer has long been considered as a short-term, poor prognosis, chemoresistant disease. Until the early 1990s, the impact of systemic…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Primary peritoneal tumors: report on a series of eight cases and review of the literature by Clippe, Christine, Freyer, Gilles, Bizollon, Marie-Hélène, Raudrant, Daniel, Gilly, François, Vitrey, Danièle, Ligneau, Blandine, Trillet-Lenoir, Véronique

    Published in Bulletin du cancer (01-04-2002)
    “…Primary peritoneal tumors are rare and yet not well-known malignancies. We report here the clinical cases of 8 patients who were referred to our institution…”
    Get full text
    Journal Article
  14. 14